{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics","slug":"episode-56-part-two-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics","published_at":"2025-07-15T09:28:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-56-part-two-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-56-part-two-michael-tolentino-md-co-foun3dj","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2088872/c1e-kdjd3hgdrp8cx74vq-7z92m8v8akg3-s62ikm.mp3","summary":"How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael Tolentino, MD, Co-Founder and Head Scientific Consultant at Aviceda Therapeutics. Join host Chris O'Brien as he and Dr. Tolentino, explore the traits of top problem solvers, the power of communication, and how silos and \"bad apples\" can undermine today's biotechs. Okay, let's start the podcast!","meta_description":"How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Micha…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2368,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-56-part-two-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-56-part-two-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}